Psychotropic medications prescribing trends in adolescents: A nationwide population-based study in Taiwan

International Journal for Quality in Health Care

Volumn 29, Issue 6, 2017, Pages 861-866

  Tsai, Chin Yen ^a   Yang, Hsuan Chia ^b   Islam, Mohaimenul ^b   Hsieh, Wan Shan ^c   Juan, Shing Hwa ^a   Chen, Jiang Chen ^b   Khan, Hafsah Arshed Ali ^b   Jian, Wen Shan ^b,d  

^a YUAN'S GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

Adolescent; Epidemiology; National health insurance; Psychotropic medications

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADOLESCENT; ADOLESCENT HEALTH; ANXIETY DISORDER; ARTICLE; CHILD; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; SEX DIFFERENCE; TAIWAN; TAIWANESE; TREATMENT DURATION; TREND STUDY; AGE; CLINICAL PRACTICE; COHORT ANALYSIS; SEX FACTOR; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

ADOLESCENT; AGE FACTORS; CHILD; COHORT STUDIES; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; PRACTICE PATTERNS, PHYSICIANS'; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; SEX FACTORS; TAIWAN; TIME FACTORS;

EID: 85040602135     PISSN: 13534505     EISSN: 14643677     Source Type: Journal    
DOI: 10.1093/intqhc/mzx123     Document Type: Article

References (36)

1. Council NR Preventing mental, emotional, and behavioral disorders among young people: Progress and possibilities: National Academies Press, 2009
2. Control CfD, Prevention. Web-based Injury Statistics Query and Reporting System (WISQARS). Atlanta, GA: National Center for Injury Prevention and Control. Retrieved March 15, 2012. 2012
3. Olfson M, Blanco C, Wang S et al. National trends in the mental health care of children, adolescents, and adults by office-based physicians. JAMA Psychiatry 2014;71:81-90
4. Tan C-H, Shinfuku N, Sim K. Psychotropic prescription practices in east Asia: looking back and peering ahead. Curr Opin Psychiatry 2008;21: 645-50
5. Findling RL, Robb A, Nyilas M et al. A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia. Am J Psychiatry 2008;165:1432-41
6. Tohen M, Kryzhanovskaya L, Carlson G et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry 2007;164:1547-56
7. Tarricone I, Gozzi BF, Serretti A et al. Weight gain in antipsychotic-naive patients: a review and meta-analysis. Psychol Med 2010;40:187-200
8. Correll CU, Manu P, Olshanskiy V et al. Cardiometabolic risk of secondgeneration antipsychotic medications during first-time use in children and adolescents. JAMA 2009;302:1765-73
9. Munch G, Godart N. Guidelines for the prescription of mood stabilizers for adolescents: A literature review. L'Encephale. 2016
10. Franke C, Fegert JM, Krüger U et al. Prescriptions of psychotropic drugs to children and adolescents in Germany. Zeitschrift fur Kinder-und Jugendpsychiatrie und Psychotherapie 2016;44:259-74
11. Ravindran AV, da Silva TL. Complementary and alternative therapies as add-on to pharmacotherapy for mood and anxiety disorders: A systematic review. J Affect Disord 2013;150:707-19
12. Clavenna A, Rossi E, DeRosa M et al. Use of psychotropic medications in Italian children and adolescents. Eur J Pediatr 2007;166:339-47
13. Zito JM, Safer DJ, Janhsen K et al. A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health 2008;2:26
14. Cyranowski JM, Frank E, Young E et al. Adolescent onset of the gender difference in lifetime rates of major depression: a theoretical model. Arch Gen Psychiatry 2000;57:21-7
15. Blakemore S-J. The social brain in adolescence. Nat Rev Neurosci 2008; 9:267-77
16. Lewinsohn PM, Rohde P, Klein DN et al. Natural course of adolescent major depressive disorder: I. Continuity into young adulthood. J Am Acad Child Adolescent Psychiatry 1999;38:56-63
17. Hankin BL, Abramson LY, Moffitt TE et al. Development of depression from preadolescence to young adulthood: emerging gender differences in a 10-year longitudinal study. J Abnorm Psychol 1998;107:128
18. Olfson M, King M, Schoenbaum M. Treatment of young people with antipsychotic medications in the United States. JAMA Psychiatry 2015; 72:867-74
19. Barbui C, Esposito E, Cipriani A. Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. Can Med Assoc J 2009;180:291-7
20. Robertson HT, Allison DB. Drugs associated with more suicidal ideations are also associated with more suicide attempts. PLoS ONE 2009;4:e7312
21. Karanges E, McGregor IS. Antidepressants and adolescent brain development. Future Neurol 2011;6:783-808
22. Isacsson G. Suicide prevention-a medical breakthrough? Acta Psychiatr Scand 2000;102:113-7
23. Shaffer D, Craft L. Methods of adolescent suicide prevention. J Clin Psychiatry 1999;60:70-4
24. Hall WD, Mant A, Mitchell PB et al. Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis. BMJ 2003;326:1008
25. Altshuler L, Kiriakos L, Calcagno J et al. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. J Clin Psychiatry 2001;62:612-6
26. Altshuler L, Suppes T, Black D et al. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry 2003;160:1252-62
27. Möller H-J, Grunze H. Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? Eur Arch Psychiatry Clin Neurosci 2000;250:57-68
28. Boyd CJ, Austic E, Epstein-Ngo Q et al. A prospective study of adolescents' nonmedical use of anxiolytic and sleep medication. Psychol Addict Behav 2015;29:184
29. Inagaki T, Miyaoka T, Tsuji S et al. Adverse reactions to zolpidem: case reports and a review of the literature. Prim Care Companion J Clin Psychiatry 2010;12:PCC.09r00849
30. Steinhausen HC, Bisgaard C. Nationwide time trends in dispensed prescriptions of psychotropic medication for children and adolescents in Denmark. Acta Psychiatr Scand 2014;129:221-31
31. Alessi-Severini S, Biscontri RG, Collins DM et al. Ten years of antipsychotic prescribing to children: a Canadian population-based study. Can J Psychiatry 2012;57:52-8
32. Karanges EA, Stephenson CP, McGregor IS. Longitudinal trends in the dispensing of psychotropic medications in Australia from 2009-2012: focus on children, adolescents and prescriber specialty. Aust NZ J Psychiatry 2014;48:917-31
33. Bishop JR, Pavuluri MN. Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia. Neuropsychiatr Dis Treat 2008;4:55
34. Islam MM, Iqbal U, Walther BA et al. Gender-based personalized pharmacotherapy: a systematic review. Arch Gynecol Obstet 2017;295: 1-13
35. Haack S, Seeringer A, Thürmann PA et al. Sex-specific differences in side effects of psychotropic drugs: genes or gender? Pharmacogenomics 2009; 10:1511-26
36. Oberlander TF, Miller AR. Antidepressant use in children and adolescents: practice touch points to guide paediatricians. Paediatrics Child Health 2011;16:549-53